Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2003
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236433 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
12/25/2003US20030236430 Mixing aspartic acid with tert-butyl acetate to form slurries, then adding boron trifluoride diethyl etherate, while stirring to form aspartic acid, di-tert-butyl ester; ester interchange
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236415 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236220 Mucin synthesis inhibitors
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/24/2003WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein
12/24/2003WO2003057717A3 Crystallization of amino acids using ultrasonic agitation
12/24/2003WO2003042136A3 Process for the production of l-dopa ethyl ester
12/24/2003WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667336 Phenyl-thienyl-prop-1-en-3-yl-sarcosine derivatives; nontoxic; neurological and neuropsychiatric disorders; glycine transporter sequestering
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003CA2087084C Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
12/18/2003WO2003104430A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103686A1 Thrombopoietin mimetics
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003WO2003103602A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/18/2003CA2488773A1 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2487414A1 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/17/2003EP1371630A2 Aminopolycarboxylic acid aqueous solution composition and stabilization method of aminopolycarboxylic acid
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/16/2003US6664412 Method for producing lysine derivative
12/16/2003US6663898 Carbon-substituted diketopiperazine delivery systems
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/16/2003CA2087085C Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
12/11/2003WO2003102150A2 Multi-functional polyamines for delivery of biologically-active polynucleotides
12/11/2003WO2003101952A2 Polyamine-mediated transfection
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003WO2001002075A9 Method for using laser light to control crystal form
12/11/2003US20030229254 Process for the preparation of 3, 3-dimethylbutanal
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229145 Analgesics; amino acid drug
12/11/2003US20030229144 Anti-epileptogenic agents
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/10/2003EP1368410A2 Comonomer compositions for production of imide-containing polyamino acids
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368335A2 Novel amino dicarboxylic acid derivatives with pharmaceutical properties
12/10/2003EP1368303A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368300A1 Substituted amino dicarboxylic acid derivatives
12/10/2003EP1368287A1 Process for a homogeneously catalyzed c-c coupling reaction
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099758A1 PROCESS FOR THE PREPARATION OF A N,N-DIAMINO AMINO ACID-β-HYDROXY DISUCCINIC ACID
12/04/2003WO2003099746A1 Method for the production of 18f-fluorinated alpha acids
12/04/2003WO2003099269A1 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
12/04/2003US20030225298 Reacting bis-(phosophonomethyl)urea or urea with carbon monoxide and formaldehyde in the presence of catalysts and solvents to form N-(phosphonomethyl)glycine
12/04/2003US20030225287 Synthesis of chiral 2-alkyl amino acids
12/04/2003US20030225161 GABA and L-glutamic acid analogs for antiseizure treatment
12/04/2003US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003CA2487273A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003EP1366016A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1123301B1 Chelating agents for radioimmunotherapy
12/03/2003EP0946295B1 Catalyst for dehydrogenation of amino alcohols to amino carboxylic acids or of ethylene glycol (derivatives) to oxycarboxylic acids, method for their production and their use
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/02/2003US6657085 By reacting nitro compounds with hydrazine at elevated temperature in the presence of an aqueous base; intermediates in the preparation of herbicides of the isobenzofuranone type
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6656498 Cationic liposomes for gene transfer
12/02/2003CA2192256C Polyamino acid ester copolymers
11/2003
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097578A1 Method for producing 2-(4-n, n-dialkylamino-2-hydroxybenzoyl)benzoates
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2002072020A3 Novel anti-adhesive compounds and uses thereof
11/27/2003US20030220522 Salt formation by reacting ammonium with a mixture of maleic anhydride, alkali metal hydroxide and water, then reacting with metal oxides, metal hydroxides; use as trace element fertilizers or slug and snail pellets in agriculture
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 215